Delivery Order SPE2D021DA002-SPE2D326F1154
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $4,670.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, utilizes firm fixed-price terms and carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its headquarters location....
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in single-dose vials on October 20, 2025. The delivery order, with an ultimate completion date of November 10, 2025, carries no set-aside designation, allowing the woman-owned small business to compete directly against other qualified vendors. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, is the sole awardee with no identified...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,783.80 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in one-dose vial quantities. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order, issued on November 5, 2025, with an...
- The Defense Logistics Agency's Medical Supply Chain division awarded a firm fixed-price delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. for yellow fever vaccine (YF-VAX) on November 7, 2025, with completion targeted for November 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, awarded on November 4, 2025, with an ultimate completion date of November 26, 2025, represents a routine pharmaceutical supply requirement supporting Department of Defense medical operations. The award carries no...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,670.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $36,196.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. This firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025, and carries no set-aside designation, indicating the award was made through...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F1154Delivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $4,670.56 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) dose vials on November 17, 2025. This firm fixed-price delivery order, which has no set-aside designation, is structured as a one-time purchase with an ultimate completion date of November 18, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected to fulfill this requirement based on its established capability and competitive positioning within the federal pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, awarded on November 13, 2025, carries a ceiling value of $499.999 billion and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply the full range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. The YF-VAX delivery order represents one of numerous awards issued to the contractor within this broader framework to meet recurring medical supply requirements across military healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 11/17/25 |